Validation of the Thai version of SARC-F, MSRA-7, and MSRA-5 questionnaires compared to AWGS 2019 and sarcopenia risks in older patients at a medical outpatient clinic
Objectives: To validate the Thai Strength, Assistance with walking, Rise from a chair, Climb stairs and Falls (SARC-F), and 2 Mini Sarcopenia Risk Assessment (MSRA-5, and MSRA-7) questionnaires for sarcopenia screening in older patients in the medical outpatient setting, and to assess the improvemen...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-12-01
|
Series: | Osteoporosis and Sarcopenia |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405525520301060 |
id |
doaj-7063cd408167419289bf5b5245b2ac9a |
---|---|
record_format |
Article |
spelling |
doaj-7063cd408167419289bf5b5245b2ac9a2020-12-31T04:43:00ZengElsevierOsteoporosis and Sarcopenia2405-52552020-12-0164205211Validation of the Thai version of SARC-F, MSRA-7, and MSRA-5 questionnaires compared to AWGS 2019 and sarcopenia risks in older patients at a medical outpatient clinicPhuriwat Akarapornkrailert0Weerasak Muangpaisan1Apinya Boonpeng2Dao Daengdee3Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, ThailandDepartment of Preventive and Social Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; Corresponding author. Department of Preventive and Social Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, 2 Wang Lang Road, Bangkok Noi, Bangkok, 10700, Thailand.Bangkhunthian Geriatric Hospital, Bangkok Medical Service Department, Bangkok, ThailandBangkhunthian Geriatric Hospital, Bangkok Medical Service Department, Bangkok, ThailandObjectives: To validate the Thai Strength, Assistance with walking, Rise from a chair, Climb stairs and Falls (SARC-F), and 2 Mini Sarcopenia Risk Assessment (MSRA-5, and MSRA-7) questionnaires for sarcopenia screening in older patients in the medical outpatient setting, and to assess the improvements of the diagnostic accuracy by adapting the parameters in the SARC-F, MSRA-7, and MSRA-5 questionnaires. Risk factors for sarcopenia are also investigated. Methods: Thai SARC-F, MSRA-7, and MSRA-5 questionnaires were translated backwards and forwards. Content validity and test–retest reliability were analyzed. Reliability analysis was used for SARC-F, MSRA-7, and MSRA-5 scores to increase the sensitivity and specificity. The sensitivity, specificity, likelihood ratio, and area under the receiver operating characteristic curves (AUCs) were analyzed. Results: The prevalence of sarcopenia was 22.7% (65 of 286 patients). The sensitivity of the SARC-F, MSRA-7, and MSRA-5 questionnaires was 21.5%, 72.3%, and 61.5%, respectively. The specificity was 93.7%, 43%, and 67.4%, respectively. The AUCs were 0.58, 0.58, and 0.65, respectively. After weighting and adjusting the scores for the least responded-to items of the MSRA-5, the sensitivity increased to 82.6%, specificity to 43.4%, and AUC to 0.65. Multivariate analysis showed that the associated factors of sarcopenia were age [odds ratio (OR) = 5.92], body mass index < 18.5 [OR = 9.59], and currently working [OR = 0.11]. Conclusions: The modified MSRA-5 improved the sensitivity and diagnostic accuracy for screening for sarcopenia. It is potentially useful for screening for sarcopenia in settings with limited resources for bioelectrical impedance analysis, time, or health personnel.http://www.sciencedirect.com/science/article/pii/S2405525520301060SarcopeniaSARC-FMSRA-7MSRA-5QuestionnairesScreening |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Phuriwat Akarapornkrailert Weerasak Muangpaisan Apinya Boonpeng Dao Daengdee |
spellingShingle |
Phuriwat Akarapornkrailert Weerasak Muangpaisan Apinya Boonpeng Dao Daengdee Validation of the Thai version of SARC-F, MSRA-7, and MSRA-5 questionnaires compared to AWGS 2019 and sarcopenia risks in older patients at a medical outpatient clinic Osteoporosis and Sarcopenia Sarcopenia SARC-F MSRA-7 MSRA-5 Questionnaires Screening |
author_facet |
Phuriwat Akarapornkrailert Weerasak Muangpaisan Apinya Boonpeng Dao Daengdee |
author_sort |
Phuriwat Akarapornkrailert |
title |
Validation of the Thai version of SARC-F, MSRA-7, and MSRA-5 questionnaires compared to AWGS 2019 and sarcopenia risks in older patients at a medical outpatient clinic |
title_short |
Validation of the Thai version of SARC-F, MSRA-7, and MSRA-5 questionnaires compared to AWGS 2019 and sarcopenia risks in older patients at a medical outpatient clinic |
title_full |
Validation of the Thai version of SARC-F, MSRA-7, and MSRA-5 questionnaires compared to AWGS 2019 and sarcopenia risks in older patients at a medical outpatient clinic |
title_fullStr |
Validation of the Thai version of SARC-F, MSRA-7, and MSRA-5 questionnaires compared to AWGS 2019 and sarcopenia risks in older patients at a medical outpatient clinic |
title_full_unstemmed |
Validation of the Thai version of SARC-F, MSRA-7, and MSRA-5 questionnaires compared to AWGS 2019 and sarcopenia risks in older patients at a medical outpatient clinic |
title_sort |
validation of the thai version of sarc-f, msra-7, and msra-5 questionnaires compared to awgs 2019 and sarcopenia risks in older patients at a medical outpatient clinic |
publisher |
Elsevier |
series |
Osteoporosis and Sarcopenia |
issn |
2405-5255 |
publishDate |
2020-12-01 |
description |
Objectives: To validate the Thai Strength, Assistance with walking, Rise from a chair, Climb stairs and Falls (SARC-F), and 2 Mini Sarcopenia Risk Assessment (MSRA-5, and MSRA-7) questionnaires for sarcopenia screening in older patients in the medical outpatient setting, and to assess the improvements of the diagnostic accuracy by adapting the parameters in the SARC-F, MSRA-7, and MSRA-5 questionnaires. Risk factors for sarcopenia are also investigated. Methods: Thai SARC-F, MSRA-7, and MSRA-5 questionnaires were translated backwards and forwards. Content validity and test–retest reliability were analyzed. Reliability analysis was used for SARC-F, MSRA-7, and MSRA-5 scores to increase the sensitivity and specificity. The sensitivity, specificity, likelihood ratio, and area under the receiver operating characteristic curves (AUCs) were analyzed. Results: The prevalence of sarcopenia was 22.7% (65 of 286 patients). The sensitivity of the SARC-F, MSRA-7, and MSRA-5 questionnaires was 21.5%, 72.3%, and 61.5%, respectively. The specificity was 93.7%, 43%, and 67.4%, respectively. The AUCs were 0.58, 0.58, and 0.65, respectively. After weighting and adjusting the scores for the least responded-to items of the MSRA-5, the sensitivity increased to 82.6%, specificity to 43.4%, and AUC to 0.65. Multivariate analysis showed that the associated factors of sarcopenia were age [odds ratio (OR) = 5.92], body mass index < 18.5 [OR = 9.59], and currently working [OR = 0.11]. Conclusions: The modified MSRA-5 improved the sensitivity and diagnostic accuracy for screening for sarcopenia. It is potentially useful for screening for sarcopenia in settings with limited resources for bioelectrical impedance analysis, time, or health personnel. |
topic |
Sarcopenia SARC-F MSRA-7 MSRA-5 Questionnaires Screening |
url |
http://www.sciencedirect.com/science/article/pii/S2405525520301060 |
work_keys_str_mv |
AT phuriwatakarapornkrailert validationofthethaiversionofsarcfmsra7andmsra5questionnairescomparedtoawgs2019andsarcopeniarisksinolderpatientsatamedicaloutpatientclinic AT weerasakmuangpaisan validationofthethaiversionofsarcfmsra7andmsra5questionnairescomparedtoawgs2019andsarcopeniarisksinolderpatientsatamedicaloutpatientclinic AT apinyaboonpeng validationofthethaiversionofsarcfmsra7andmsra5questionnairescomparedtoawgs2019andsarcopeniarisksinolderpatientsatamedicaloutpatientclinic AT daodaengdee validationofthethaiversionofsarcfmsra7andmsra5questionnairescomparedtoawgs2019andsarcopeniarisksinolderpatientsatamedicaloutpatientclinic |
_version_ |
1724364990410915840 |